Galderma Group AG
SIX:GALD
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
53
86.74
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CHF.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Galderma Group AG
Non-Reccuring Items
Galderma Group AG
Non-Reccuring Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Non-Reccuring Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
Galderma Group AG
SIX:GALD
|
Non-Reccuring Items
-41.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Transocean Ltd
NYSE:RIG
|
Non-Reccuring Items
-$634m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
0%
|
CAGR 10-Years
14%
|
|
|
M
|
MoonLake Immunotherapeutics
NASDAQ:MLTX
|
Non-Reccuring Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Sealsq Corp
NASDAQ:LAES
|
Non-Reccuring Items
$2.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
T
|
TalkPool AG
STO:TALK
|
Non-Reccuring Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
R
|
R&S Group Holding AG
SIX:RSGN
|
Non-Reccuring Items
CHf0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Galderma Group AG
Glance View
Galderma Group AG is a global leader in dermatology, committed to delivering innovative solutions that enhance the health and beauty of skin. Founded in 1981, the company has cultivated a rich portfolio of products spanning prescription medications and consumer skin health brands. It operates under key brands like Restylane, used for aesthetic solutions, and Cetaphil, known for its gentle skincare products. With a strong emphasis on research and development, Galderma consistently invests in cutting-edge technologies and clinical advancements to meet the diverse needs of its patients and consumers worldwide. As the skin health market continues to expand—driven by increasing awareness of skin conditions and the rise in demand for aesthetic treatments—Galderma is strategically positioned to capture significant growth opportunities. The company's proactive approach to sustainability and focus on patient-centric solutions further solidify its reputation in the industry. For investors, Galderma represents not just a steady performer in the healthcare sector, but also an innovative player navigating the evolving landscape of dermatology. By prioritizing both efficacy and consumer satisfaction, Galderma is not only promoting healthier skin but is also capitalizing on a rapidly growing market—making it a compelling addition to any investment portfolio.
See Also
What is Galderma Group AG's Non-Reccuring Items?
Non-Reccuring Items
-41.2m
Based on the financial report for Dec 31, 2023, Galderma Group AG's Non-Reccuring Items amounts to -41.2m .
What is Galderma Group AG's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 1Y
43%
Over the last year, the Non-Reccuring Items growth was 43%.
You don't have any saved screeners yet
